Appears On
Episode Appearances
Biotech Hangout · May 8, 2026
Episode 182 - May 8, 2026
“Covered M&A activity, China biotech asset licensing, and FDA Commissioner's Voucher program credibility issues”
Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns
View Analysis